Page last updated: 2024-11-03

procainamide and B16 Melanoma

procainamide has been researched along with B16 Melanoma in 2 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Research Excerpts

ExcerptRelevanceReference
" The toxicity of these compounds against hepatoma cells (MH3924A) and, to a lesser extent, against mouse fibroblast (NIH 3T3) and cervix carcinoma (HeLa) cells was also enhanced, but they were not as toxic as dacarbazine (HeLa)."1.32Alkylating benzamides with melanoma cytotoxicity. ( Bauder-Wüst, U; Eisenhut, M; Haberkorn, U; Mier, W; Mohammed, A; Schönsiegel, F; Wolf, M, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, HJ1
Kim, DY1
Park, JH1
Yang, SD1
Hur, MG1
Min, JJ1
Yu, KH1
Wolf, M1
Bauder-Wüst, U1
Mohammed, A1
Schönsiegel, F1
Mier, W1
Haberkorn, U1
Eisenhut, M1

Other Studies

2 other studies available for procainamide and B16 Melanoma

ArticleYear
Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging.
    Bioorganic & medicinal chemistry letters, 2012, Aug-15, Volume: 22, Issue:16

    Topics: Animals; Benzamides; Cell Line, Tumor; Gallium Radioisotopes; Half-Life; Heterocyclic Compounds, 1-R

2012
Alkylating benzamides with melanoma cytotoxicity.
    Melanoma research, 2004, Volume: 14, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Cell Line, Tumor; Cel

2004